---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-052755"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2024-12-31T23:59:59+00:00"
generated_at: "2026-05-28T22:36:34.362673+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health receives Nasdaq delisting notice for MVLS non-compliance

## Summary
- Notice received Dec 31, 2024; company failed to regain $35M MVLS requirement by Dec 30, 2024 deadline.
- Unless appeal requested by Jan 7, 2025 with $20,000 fee, common stock delisted Jan 10, 2025.
- Company intends to appeal; appeal stays delisting pending Nasdaq decision.
- No assurance of success; risk of delisting from Nasdaq Capital Market remains.

## SEC filing metadata
- accession: 0001493152-24-052755
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2024-12-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315224052755/0001493152-24-052755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315224052755/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-052755
- JSON: https://secwatch.observer/filing/0001493152-24-052755.json
- Plain text: https://secwatch.observer/filing/0001493152-24-052755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
